Implementing a Nicotine Cap to Make America Healthy Again

Clicks: 16
ID: 327448
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #89 of 168 articles by views in Health Affairs Scholar

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 168 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract The U.S. Department of Health and Human Services’ (HHS) "Make America Healthy Again" initiative cannot eradicate the root causes of the nation’s chronic disease epidemic without tackling cigarette smoking, which kills over 480,000 Americans and costs $600 billion annually. This commentary reinvigorates a pivotal 2017 FDA framework by urging the current administration to finalize the proposed rule establishing a maximum nicotine cap in all cigarettes and selected combusted tobacco. Evidence demonstrates that capping nicotine at non-addictive levels (∼95% reduction) rapidly decreases dependence and accelerates smoking cessation. The FDA projects that a nicotine cap will prevent 4.3 million smoking-related deaths by 2100 while saving $1.1 trillion annually in healthcare and productivity costs over forty years. To maximize these gains, we outline two supporting strategies. First, the administration must substantially fund the nation's under-resourced smoking cessation infrastructure to meet the inevitable surge in quitting. Second, provide adults who smoke evidence-based information on the full spectrum of quitting smoking options by communicating the tobacco/nicotine continuum of risk, that is, that combusted products (e.g., cigarettes) carry the greatest risk of disease, non-combusted products (e.g., e-cigarettes) are likely to pose less risk than cigarettes, and medicinal nicotine products (e.g., patches) are the safest option.
Reference Key
openalex_W7207617443 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dana Mowls Carroll, Dorothy K. Hatsukami, Olivia A Wackowski, F. Joseph McClernon, Eric C. Donny, Mitchell Zeller
Are you one of these authors? Claim your profile
Journal Health Affairs Scholar
Year 2026
DOI
10.1093/haschl/qxag239
URL
https://doi.org/10.1093/haschl/qxag239
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.